A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders

Addiction

Volumn 100, Issue 12, 2005, Pages 1868-1874

  Carpentier, Pieter J ^a   De Jong, Cor A J ^a,b   Dijkstra, Boukje A G ^a,b   Verbrugge, Cor A G ^a   Krabbe, Paul F M ^c  

^a Novadic   (Netherlands)

^b Nijmegen Institute for Scientist Practitioners in Addiction NISPA   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Attention deficit hyperactivity disorder; Methylphenidate; Placebo response; Placebo controlled trial; Substance use disorders

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MULTIVARIATE ANALYSIS OF VARIANCE; OUTCOMES RESEARCH; PILOT STUDY; RATING SCALE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PILOT PROJECTS; PSYCHOMETRICS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 28844461787     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2005.01272.x     Document Type: Article

References (27)

1. Barkley, R. A. & Murphy, K. R. (1998) Attention-Deficit Hyperactivity Disorder. A Clinical Workbook, 2nd edn. New York: Guilford Press.
2. Biederman, J., Wilens, T., Mick, E., Milberger, S., Spencer, T. J. & Faraone, S. V. (1995) Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry, 152, 1652-1658.
3. Castaneda, R., Levy, R., Hardy, M. & Trujillo, M. (2000) Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatric Services, 51, 169-171.
4. Clure, C., Brady, K. T., Saladin, M. E., Johnson, D., Waid, R. & Rittenbury, M. (1999) Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. American Journal of Drug and Alcohol Abuse, 25, 441-448.
5. DuPaul, G. J., Power, T. J., Anastopoulos, A. D. & Reid, R. (1998) ADHD Rating Scale-IV Checklists, Norms and Clinical Interpretation. New York: Guilford Press.
6. Endicott, J., Spitzer, R. L., Fleiss, J. L. & Cohen, J. (1976) The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766-777.
7. Faraone, S. V., Spencer, T., Aleardi, M., Pagano, C. & Biederman, J. (2004) Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 24, 24-29.
8. Hiller, W., Zaudig, M. & Mombour, W. (1990) Development of diagnostic checklists for use in routine clinical care. Archives of General Psychiatry, 47, 782-784.
9. Huss, M. & Lehmkuhl, U. (2002) Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies. Journal of Attention Disorders, 6, S65-S71.
10. Khan, A., Detke, M., Khan, S. R. & Mallinckrodt, C. (2003) Placebo response and antidepressant clinical trial outcome. Journal of Nervous and Mental Disease, 191, 211-218.
11. Kooij, J. J. S., Burger, H., Boonstra, A. M., van der Linden, P. D., Kalma, L. E. & Buitelaar, J. K. (2004) Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder (ADHD). A randomised placebo-controlled double-blind cross-over trial. Psychological Medicine, 34, 973-982.
12. Kuperman, S., Perry, P. J., Gaffney, G. R., Lund, B. C., Bever-Stille, K. A., Arndt, S. et al. (2001) Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Annals of Clinical Psychiatry, 13, 129-134.
13. Levin, F. R., Evans, S. M. & Kleber, H. D. (1999) Practical guidelines for the treatment of substance abusers with adult attention-deficit/hyperactivity disorder. Psychiatric Services, 50, 1001-1003.
14. Levin, F. R., Evans, S. M., McDowell, D. M., Brooks, D. J. & Nunes, E. (2002) Bupropion treatment for cocaine abuse and adult attention-deficit/ hyperactivity disorder. Journal of Addictive Diseases, 21, 1-16.
15. Levin, F. R., Evans, S. M., McDowell, D. M. & Kleber, H. D. (1998) Methylphenidate treatment for cocaine abusers with adult attention-deficit/ hyperactivity disorder: a pilot study. Journal of Clinical Psychiatry, 59, 300-305.
16. Mattes, J. A., Boswell, L. & Oliver, H. (1984) Methylphenidate effects on symptoms of attention deficit disorder in adults. Archives of General Psychiatry, 41, 1059-1063.
17. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G. et al. (1992) The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9, 199-213.
18. Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J. et al. (2003) Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biological Psychiatry, 53, 112-120.
19. Schubiner, H., Saules, K. K., Arfken, C. L., Johanson, C. E., Schuster, C. R., Lockhart, N. et al. (2002) Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology, 10, 286-294.
20. Schubiner, H., Tzelepis, A., Isaacson, J. H., Warbasse, L. H. III, Zacharek, M. & Musial, J. (1995) The dual diagnosis of attention-deficit/ hyperactivity disorder and substance abuse: case reports and literature review. Journal of Clinical Psychiatry, 56, 146-150.
21. Somoza, E. C., Winhusen, T. M., Bridge, T. P., Rotrosen, J. P., Vanderburg, D. G., Harrer, J. M. et al. (2004) An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. Journal of Addictive Diseases, 23, 77-92.
22. Spencer, T., Wilens, T., Biederman, J., Faraone, S. V., Ablon, J. S. & Lapey, K. (1995) A double-blind, cross-over comparison of methylphenidate and placebo in adults with childhood-onset atlention-deficit/hyperactivity disorder. Archives of General Psychiatry, 52, 434-443.
23. Wender, P. H., Reimherr, F. W., Wood, D. & Ward, M. (1985) A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. American Journal of Psychiatry, 142, 547-552.
24. Wilens, T. E. (2004) Impact of ADHD and its treatment on substance abuse in adults. Journal of Clinical Psychiatry, 65, 38-45.
25. Wilens, T. E., Biederman, J., Spencer, T. J. & Frances, R. J. (1994) Comorbidity of attention-deficit hyperactivity and substance use disorders. Hospital and Community Psychiatry, 45, 421-435.
26. Wilens, T. E., Faraone, S. V., Biederman, J. & Gunawardene, S. (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111, 179-185.
27. Wilson, J. J. & Levin, F. R. (2001) Attention deficit hyperactivity disorder (ADHD) and substance use disorders. Current Psychiatry Reports, 3, 497-506.